FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055643 [Registered on: 25/07/2023] Trial Registered Prospectively
Last Modified On: 05/08/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Preventive
Screening
Process of Care Changes
Behavioral 
Study Design  Cluster Randomized Trial 
Public Title of Study   Improving the coverage of high priority health services in rural and tribal area of Gujarat 
Scientific Title of Study   Effectiveness of an comprehensive primary health care service delivery model that is enabled through use of variety of digital health solutions to improve the coverage and quality of selected, high-priority health services in a tribal area of Gujarat, India: A clustered randomized control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Version 3 on 24th September, 2022  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shrey Desai 
Designation  Director, Research 
Affiliation  SEWA Rural 
Address  SEWA Rural, Department of community health and research, Tower road, Jhagadia

Bharuch
GUJARAT
393110
India 
Phone  09429109050  
Fax    
Email  sdesai1977@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Shrey Desai 
Designation  Director, Research 
Affiliation  SEWA Rural 
Address  SEWA Rural, Department of community health and research, Tower road, Jhagadia

Bharuch
GUJARAT
393110
India 
Phone  09429109050  
Fax    
Email  sdesai1977@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Shrey Desai 
Designation  Director, Research 
Affiliation  SEWA Rural 
Address  SEWA Rural, Department of community health and research, Tower road, Jhagadia

Bharuch
GUJARAT
393110
India 
Phone  09429109050  
Fax    
Email  sdesai1977@yahoo.com  
 
Source of Monetary or Material Support  
SEWA Rural, Department of Community Health and Research, Tower Road, Jhagadia 
 
Primary Sponsor  
Name  Bill and Melinda Gates Foundation 
Address  570 Mercer St, Seattle, WA 98109 
Type of Sponsor  Other [Other USA based philanthropic organization.] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shrey Desai  SEWA Rural  Department of Community Health and Research, Tower Road, Jhagadia
Bharuch
GUJARAT 
9429109050

sdesai1977@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SEWA Rural Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Newly married couples, Infants.  
Patients  (1) ICD-10 Condition: R030||Elevated blood-pressure reading, without diagnosis of hypertension, (2) ICD-10 Condition: E118||Type 2 diabetes mellitus with unspecified complications, (3) ICD-10 Condition: F99||Mental disorder, not otherwise specified, (4) ICD-10 Condition: D578||Other sickle-cell disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Comprehensive primary health service delivery intervention/model  The duration of intervention is six years. (1) Population-based approach: Population enumeration, Generating at-risk population from population enumeration line list, screening of at-risk population (2) Patient and family-centred care: Provide treatment near patients’ homes through village clinics, treatment of multiple morbidities in patients and home visits to involve family members and address sociocultural factors (3) Team based collaborative care with linkage with secondary-tertiary level care facilities: Technology-based workflow that enables continuum of care through various cadre of health providers, mobilization of target population by village based workers, screening (for HTN, DM, mental health disorder, anemia) by mid level providers, confirmation of diagnosis and initiation of treatment by a medical officer/secondary level provider. Mid-level providers and village-level health workers will provide continuity of treatment at village clinics to ensure adherence and behavior changes, referral to medical officer/secondary level provider in case complications or disease control is not as expected, program management team ensure supportive supervision and logistics (4) Bringing care near to the homes of the citizens: Screening at the household level, village clinics, home-based care, telehealth in case referral to secondary level care is not possible (5) Digital health solutions: Mobile phone and web applications as job-aid for all health providers. Job-aid tools that will be used are digital checklists, reminders, scheduling, videos, algorithms, and decision support. Web application to provide timely information to the program management team and medical officer for monitoring and supporting the program. Some of the features of the web application will include a daily checklist to track complicated cases, weekly and monthly performance reports, reminders to pay incentives, and incentive and supply management.  
Comparator Agent  Control arm  The usual practice in the control area where the current level of services provided by the government and other agencies will continue.  
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All those living in the study area  
 
ExclusionCriteria 
Details  Those deny to take part in the study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary outcome 1: all-cause mortality & cardiovascular complications event, Primary outcome 2: Mortality rate among infants age between day 4 to day 365   The outcome will be assessed at baseline at the time of initiation of study and then at the end of sixth year of study  
 
Secondary Outcome  
Outcome  TimePoints 
The proportion of hypertension cases who are on treatment, the proportion of hypertension cases who are on treatment & BP is controlled, Proportion of diabetes cases who are on treatment, Proportion of diabetes cases who are on treatment and have achieved blood sugar control, Proportion of persons who were screened for oral and breast cancer among hypertension and diabetes cases who are more than 40 years of age, Treatment gap for common and severe mental health diseases among hypertension and diabetes cases who are more than 40 years of age, Proportion of individuals suffering from sickle cell disease who are consuming Tab. Hydroxyurea, Proportion of pregnant women who are not suffering from severe or moderate anemia on the day of the survey, Proportion of children (6-12 months) who are not suffering from severe or moderately severe anemia on the day of the survey, Cost-effectiveness.  Baseline, midline & end line 
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="6"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [sdesai1977@yahoo.com].

  6. For how long will this data be available start date provided 30-09-2029 and end date provided 30-09-2035?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

India is undergoing an epidemiological transition. The non-communicable diseases (NCDs) have become the dominant cause of death and disability. However, there is still a need to continue to improve the nutrition-related outcomes related to reproductive-maternal-child-adolescent (RMNCH-A) health. Unfortunately, the coverage and quality of selected high-priority NCD and RMNCH services to support India’s citizens during this epidemiological transition remain low, especially in tribal-hard to reach areas. These high-priority services include screening and management of hypertension, diabetes, mental health disorders, sepsis-pneumonia in infants anemia among pregnant women. The reasons for low coverage are multiple including implementation challenges and somewhat suboptimal design of the existing delivery model that might not be a right fit for rural, tribal populations. Some of the design-related elements include a focus on clinic-based management instead of bringing care further near to patients’ homes, inadequate task shifting instead of collaborative care across multiple levels of service delivery, and a lack of integrated data systems that support care throughout the life cycle for multiple NCD and RMNCH diseases. Frontline health workers and doctors lack job aids and capacity that empower them to provide longitudinal care for multiple diseases prevalent in the population.   

This project primarily focuses on developing and evaluating a comprehensive primary health service delivery intervention that overcomes the aforementioned design-related shortcomings and that might be a better fit for India, especially for the rural-tribal parts. The proposed six-year project aims to create a demonstration field trial site to develop and evaluate an primary health care service delivery intervention to improve mortality rates through improvement in the coverage of selected, high-priority NCD and RMNCH health services in one tribal block of the Narmada district of Gujarat, India. The components of the service delivery model/intervention will consist of (1) a population-based approach with a focus on screening and management of prioritized NCD and RMNCH health services, (2) patient and family-centered care, (3) team-based collaborative care with linkage with secondary-tertiary level care facilities and (4) bringing care near to the homes of the citizens. The digital health solutions will be used to (1) enable and facilitate the aforementioned components of the primary health care service delivery model (2) empower frontline health workers, their supervisors and citizens through job aids and data systems to support longitudinal tracking, continuum of care across various levels of care. The scope of the intervention will be high-priority NCD and RMNCH health services that have the highest impact on reducing mortality and disability.  The intervention will be delivered by a cadre of middle-level providers (nurses) supported by village-level community health workers at the village level and doctors at facilities.

The effectiveness of this initiative will be measured through a two-arm, parallel cluster randomized controlled trial over the six years in 64 villages/clusters of tribal, Dediyapada block (population of 60,000, 95% indigenous/ tribal population) of Gujarat. There will be approximately 32 clusters/villages (approximately 800-1,000 populations in each village) in each arm.  The two primary outcomes will be (1) mortality and cardiovascular complications event rate among hypertension and diabetes cases who are more than 40 years of age (2) mortality rate among infants age four days to 365 days. Mortality rate will be measured through an ongoing death surveillance system. The secondary outcomes will include the coverage and quality of high-priority NCD, RMNCH and mental health services. Outcomes will be measured by conducting household surveys at baseline, midline and post-intervention which will be compared with usual practice in the control area where the current level of services provided by the government will continue.

The primary analysis will be done by “intention to treat”. For each of the primary and secondary outcomes, effect size (95% confidence interval), after adjustment if required, would be computed.

The study findings might be useful for strengthening the health and wellness centers as well as the Ayushman Bharat Digital Health Mission (ABDM) of the Government of India, especially for rural and tribal hard to reach populations.

This study will be done by investigators from SEWA Rural, a non-profit organization in Gujarat. SEWA Rural has been working towards improving health services in rural and tribal areas of Bharuch and Narmada districts of Gujarat in close partnership with the government since 1980. 


 
Close